Fermer le menu

Member of Lyonbiopole


ENDOPLY SAS is a start-up French company, making a IIb Medical Device designed for an upper GI endoscopic use: it aims at narrowing the gastric inner space so as to create food restriction, following upon the paths of a procedure called « endo-sleeve » (e.g. Apollo System) which targets the obese population. It also competes with bariatric surgery, which entails a significant environmental footprint and complications; and it may be a valuable addition to current weight loss drugs (and vice-versa) for the heaviest patients. Our design allows upgrades that will robotize and simplify the general use of this method. IP (patent) accepted in France, filed in Europe and USA. A pilot series of 10 patients is scheduled in Sept 2024 in Prague, CE-mark (+ FDA) and sales are considered early 2026.


Application market: Gastro-enterology, Metabolic Disorders - Endocrinology

Type of activity: Medical device

Technologies: Disposable & Implants, Surgical & Medical instruments

Created on july 7th, 2021 - 1 employees



65 rue des contamines 69140 Rillieux-la-pape



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.